Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback